Association Between Specific Type 2 Diabetes Therapies and Risk of Alzheimer’s Disease and Related Dementias in Propensity-Score Matched Type 2 Diabetic Patients

OBJECTIVE: We sought to determine the impact of Type 2 Diabetes Mellitus (T2D) anti-hyperglycemic medications (A-HgM) on risk of Alzheimer’s disease (AD) and related dementias (ADRD) outcomes including vascular dementia, and non-AD dementia such as frontotemporal, Lewy body, and mixed etiology demen...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrandell-Haro, Georgina, Branigan, Gregory L., Brinton, Roberta Diaz, Rodgers, Kathleen E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120543/
https://www.ncbi.nlm.nih.gov/pubmed/35601622
http://dx.doi.org/10.3389/fnagi.2022.878304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9120543/
https://www.ncbi.nlm.nih.gov/pubmed/35601622
http://dx.doi.org/10.3389/fnagi.2022.878304

Ejemplares similares